NewAmsterdam Pharma Co N.V. (NAMS)

Insiders sold $63.3M in the past 12 months, 71% under disclosed plans; their starting stakes can't be measured from the filings. Why

Latest filing: Filed Oct 2 for a sale on Sep 30. Johannes Kastelein sold 50K shares ($1.3M) under a disclosed plan. Filing